20 related articles for article (PubMed ID: 4475982)
1. The lactate dehydrogenases in malignant and non-malignant diseases.
Oladipo OO; Ajala MO; Afonja OA
Niger Postgrad Med J; 2002 Mar; 9(1):1-6. PubMed ID: 11932752
[TBL] [Abstract][Full Text] [Related]
2. Enzymes in benign and malignant effusions.
Teloh HA
Ann Clin Lab Sci; 1977; 7(4):361-3. PubMed ID: 900863
[TBL] [Abstract][Full Text] [Related]
3. [Lactodehydrogenase and its thermostable fraction in organic fluids. Clinical value and its determination in pleural effusions and ascitic fluid].
Peña Yáñez A; Toril Illescas M; Rico Irles J; Peña Angulo JF
Rev Clin Esp; 1969 Aug; 114(4):357-64. PubMed ID: 5383303
[No Abstract] [Full Text] [Related]
4. [Value and limitations of the use of enzymatic diagnosis in malignant neoplasms. LDH zymograms, quantitative determination of GOT, GPT, LDH and MDH in blood and pleuro-abdominal effusion fluids].
Emanuelli G; Cagetti M; Congiu P; Verzetti G; Montagnani M
Quad Sclavo Diagn; 1972 Dec; 8(4):980-93. PubMed ID: 4668741
[No Abstract] [Full Text] [Related]
5. [Differential diagnostic importance of lactate dehydrogenase in exudates].
Busse K; Einert HJ
Med Klin; 1966 Sep; 61(39):1535-7. PubMed ID: 5998890
[No Abstract] [Full Text] [Related]
6. [Cytodiagnosis and general physical findings--pathophysiology of the membranes lining the body cavities and the characteristics of the body fluids].
Tajima M; Murakami S
Rinsho Byori; 1983 Sep; 31(9):961-6. PubMed ID: 6363763
[No Abstract] [Full Text] [Related]
7. [Cytological observation and LDH isoenzyme analysis of the ascitic and pleural fluids].
Miwa K; Urabe M; Ito K; Kunimi H; Takahashi M
Rinsho Byori; 1974 Oct; 22(10 Suppl):66. PubMed ID: 4475982
[No Abstract] [Full Text] [Related]
8. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation.
Drent M; Cobben NA; Henderson RF; Wouters EF; van Dieijen-Visser M
Eur Respir J; 1996 Aug; 9(8):1736-42. PubMed ID: 8866602
[TBL] [Abstract][Full Text] [Related]
9. [Ascitic fluid: benignancy and malignancy parameters].
Fluixá Carrascosa F; Rull Segura S; Devesa Jorda F; Martín Estruch A; Tur Cotaina MD; Borghol Hariri A; Pérez Serra J
Rev Esp Enferm Dig; 1996 Jan; 88(1):35-8. PubMed ID: 8615999
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
